Literature DB >> 24780726

Absolute quantification of apolipoproteins and associated proteins on human plasma lipoproteins.

Anne von Zychlinski1, Michael Williams2, Sally McCormick3, Torsten Kleffmann4.   

Abstract

Lipoprotein-associated proteins form an intrinsic part of the major plasma lipoprotein classes. There is increasing evidence that the quantity of these proteins per lipoprotein particle determines lipoprotein function including redox, inflammatory and thrombotic properties and may impact on lipoprotein-related risks for developing heart disease. However, only limited information on the relative quantity of these proteins has been published and no comprehensive absolute quantitative data providing the stoichiometry of proteins associated with lipoproteins is available to date. To address this, we performed extensive absolute quantification by mass spectrometry of 17 lipoprotein-associated proteins on VLDL, LDL, Lp(a) and HDL from healthy subjects. For the first time we show the exact stoichiometry of apolipoproteins on different lipoprotein classes. The most distinct differences were seen in the abundance of all apoCs, apoE and apoF. We further revealed strong variations between individual samples, which indicates the complexity of the protein complement of lipoproteins and can provide additional insights into lipoprotein-related risk factors. This approach has the potential to determine alterations in the protein profiles of lipoproteins in disease states such as CVD or diabetes and, if performed on large cohorts, to translate into a tool for identifying new candidate biomarkers for risk of disease. BIOLOGICAL SIGNIFICANCE: A more comprehensive picture about the protein complement on individual lipoprotein classes is the goal of lipoprotein proteomics analyses. Despite many such studies, there is a lack of absolute quantitative data on lipoproteins isolated from individual subjects. The stoichiometry of lipoprotein-associated proteins rather than their presence or absence could provide insights into an individual's predisposition for disease such as heart disease or diabetes. Our study provides a comprehensive overview of the absolute quantity of proteins on the major apolipoprotein classes VLDL, LDL, Lp(a) and HDL.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Absolute protein quantification; Cardiovascular disease; Lipoproteins; Stoichiometry of apolipoproteins

Mesh:

Substances:

Year:  2014        PMID: 24780726     DOI: 10.1016/j.jprot.2014.04.030

Source DB:  PubMed          Journal:  J Proteomics        ISSN: 1874-3919            Impact factor:   4.044


  26 in total

1.  Excessive centrifugal fields damage high density lipoprotein.

Authors:  William H Munroe; Martin L Phillips; Verne N Schumaker
Journal:  J Lipid Res       Date:  2015-04-24       Impact factor: 5.922

2.  SAA: a link between cholesterol efflux capacity and inflammation?

Authors:  Michael J Thomas; Mary G Sorci-Thomas
Journal:  J Lipid Res       Date:  2015-06-15       Impact factor: 5.922

Review 3.  The ins and outs of lipid rafts: functions in intracellular cholesterol homeostasis, microparticles, and cell membranes: Thematic Review Series: Biology of Lipid Rafts.

Authors:  Amber B Ouweneel; Michael J Thomas; Mary G Sorci-Thomas
Journal:  J Lipid Res       Date:  2020-11-07       Impact factor: 5.922

Review 4.  Unbiased and targeted mass spectrometry for the HDL proteome.

Authors:  Sasha A Singh; Masanori Aikawa
Journal:  Curr Opin Lipidol       Date:  2017-02       Impact factor: 4.776

Review 5.  The ins and outs of lipid rafts: functions in intracellular cholesterol homeostasis, microparticles, and cell membranes.

Authors:  Amber B Ouweneel; Michael J Thomas; Mary G Sorci-Thomas
Journal:  J Lipid Res       Date:  2019-12-30       Impact factor: 5.922

6.  A high-throughput mass spectrometry-based assay for large-scale profiling of circulating human apolipoproteins.

Authors:  Valentin Blanchard; Damien Garçon; Catherine Jaunet; Kevin Chemello; Stéphanie Billon-Crossouard; Audrey Aguesse; Aya Garfa; Gilles Famchon; Amada Torres; Cédric Le May; Matthieu Pichelin; Edith Bigot-Corbel; Gilles Lambert; Bertrand Cariou; Samy Hadjadj; Michel Krempf; Kalyane Bach-Ngohou; Mikaël Croyal
Journal:  J Lipid Res       Date:  2020-05-13       Impact factor: 5.922

7.  Multiple apolipoprotein kinetics measured in human HDL by high-resolution/accurate mass parallel reaction monitoring.

Authors:  Sasha A Singh; Allison B Andraski; Brett Pieper; Wilson Goh; Carlos O Mendivil; Frank M Sacks; Masanori Aikawa
Journal:  J Lipid Res       Date:  2016-02-09       Impact factor: 5.922

8.  Lipoprotein(a) Gets Worse.

Authors:  Nathalie Pamir; Sergio Fazio
Journal:  Circ Res       Date:  2020-05-07       Impact factor: 17.367

9.  A Comparative Analysis of the Lipoprotein(a) and Low-Density Lipoprotein Proteomic Profiles Combining Mass Spectrometry and Mendelian Randomization.

Authors:  Raphaëlle Bourgeois; Arnaud Girard; Nicolas Perrot; Jakie Guertin; Patricia L Mitchell; Christian Couture; Clarisse Gotti; Sylvie Bourassa; Paolo Poggio; Elvira Mass; Romain Capoulade; Corey A Scipione; Audrey-Anne Després; Patrick Couture; Arnaud Droit; Philippe Pibarot; Michael B Boffa; Sébastien Thériault; Marlys L Koschinsky; Patrick Mathieu; Benoit J Arsenault
Journal:  CJC Open       Date:  2020-12-03

Review 10.  The metabolism of lipoprotein (a): an ever-evolving story.

Authors:  Gissette Reyes-Soffer; Henry N Ginsberg; Rajasekhar Ramakrishnan
Journal:  J Lipid Res       Date:  2017-07-18       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.